Juniper Pharmaceuticals Inc (NASDAQ:JNP)

8.70
Delayed Data
As of Feb 23
 +0.35 / +4.19%
Today’s Change
3.65
Today|||52-Week Range
8.95
+79.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues20.9M11.2M14.0M13.0M
 
 
 
 
 
Cost of Goods Sold5.3M6.1M7.1M7.1M
 
 
 
 
 
Depreciation And Amortization464.0K484.0K591.0K593.0K
 
 
 
 
 
 
Operating ExpensesGross Income15.2M4.7M6.3M5.3M
 
 
 
 
 
General Expenses6.0M6.1M6.7M6.0M
 
 
 
 
 
Research And Development1.4M1.3M1.6M2.3M
 
 
 
 
 
Total Operating Expenses11.8M12.7M14.3M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.1M-1.5M-356.0K-779.0K
 
 
 
 
 
Extraordinary Charge0.000.000.00-756.0K
 
 
Interest Expense On Debt23.0K28.0K30.0K47.0K
 
 
 
 
 
Other Expenses564.0K42.0K10.0K127.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.7M-1.4M-376.0K-1.5M
 
 
 
 
 
Income Taxes-44.0K0.000.00-45.0K
 
 
 
Preferred Dividend-7.0K-7.0K-452.0K0.00
 
 
 
 
Net Income9.6M-1.4M-376.0K-1.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.9M10.8M11.0M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.88-$0.13-$0.03-$0.13
 
 
 
 
 
EPS Diluted$0.88-$0.13-$0.03-$0.13